RT Journal Article
SR Electronic
T1 Molecular diagnosis of SARS-CoV-2: a validation of saliva samples
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.20.22269618
DO 10.1101/2022.01.20.22269618
A1 da Silva, Natalia Verissimo Rodrigues
A1 Neves Pereira, Samyra Stéphane
A1 Kavalco, Karine Frehner
A1 Menegídio, Fabiano Bezerra
A1 Medeiros-Santana, Luanda
A1 Visôtto, Liliane Evangelista
A1 Pasa, Rubens
YR 2022
UL http://medrxiv.org/content/early/2022/01/21/2022.01.20.22269618.abstract
AB Nasopharyngeal swabs are the most used in sample collecting for covid-19 tests in SARS-CoV-2 molecular diagnosis. However, this sampling method presents some disadvantages, since, in addition to being dependent on imported materials, it is invasive, causes discomfort in patients, and, presents the risk of contamination for the medical collection team. This study aimed at validating saliva samples to obtain viral RNA to be used in the molecular diagnostic test for SARS-CoV-2 using the RT-qPCR technique. Results presented 93,44% concordance in in comparison to nasopharyngeal swabs sampling. Therefore, saliva samples used in SARS-CoV-2 RT-qPCR detection tests presented consistent results.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee of Federal University of Vicosa gave ethical approval for this work CAAE: 33446820.8.0000.5153I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors